Oct. 28, 2021
InBios Receives FDA EUA for COVID-19 Neutralizing Antibody ELISA
By info@inbios.com|2021-11-01T21:20:45+00:00November 1st, 2021|InBios In the News|
InBios Receives FDA EUA for COVID-19 Neutralizing Antibody ELISA
By info@inbios.com|2021-10-04T21:37:20+00:00October 4th, 2021|Conferences|
AACC Annual Meeting, Sept. 26-30, Atlanta, GA
By info@inbios.com|2021-10-04T21:18:16+00:00October 4th, 2021|InBios In the News|
InBios Receives FDA EUA for COVID-19 IgG Antibody Rapid Test
By info@inbios.com|2021-10-04T21:11:59+00:00October 4th, 2021|InBios In the News|
New Studies Suggest InBios COVID-19 POC Antigen Test Will Detect Delta Variant
By info@inbios.com|2021-10-04T21:06:33+00:00October 4th, 2021|InBios In the News|
Curebase, InBios Announce Results of Virtual Clinical Trial
By info@inbios.com|2021-05-12T20:47:28+00:00May 12th, 2021|InBios In the News|
InBios Receives FDA EUA for COVID-19 POC Antigen Detection Test
By info@inbios.com|2020-11-09T17:32:18+00:00November 9th, 2020|InBios In the News|
InBios Awarded Contract Through US Army for SCoV-2 Infection Clinical Trials
By info@inbios.com|2020-11-02T17:53:39+00:00November 2nd, 2020|InBios In the News|
InBios Awarded $12.7M to Boost Production of Two COVID-19 Diagnostics
By info@inbios.com|2020-11-02T17:45:08+00:00November 2nd, 2020|InBios In the News|
DoD Awards $12.67 Million Contract Action to InBios International Inc.
By info@inbios.com|2020-10-26T21:08:12+00:00October 26th, 2020|Conferences|
ASTMH Annual Meeting, Nov. 17-21, 2021, National Harbor, MD